Point72 Europe (London) LLP Baxter International Inc Transaction History

Point72 Europe (London) LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $11.1 Million - $12.9 Million	-293,794 Reduced 58.32%	209,937 $8.97 Million
Q4 2023 Feb 14, 2024	BUY	$31.71 - $38.95 $3.19 Million - $3.92 Million	100,631 Added 24.96%	503,731 $19.5 Million
Q3 2023 Nov 14, 2023	BUY	$37.32 - $49.29 $11.4 Million - $15 Million	305,225 Added 311.85%	403,100 $15.2 Million
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $3.91 Million - $4.67 Million	97,875 New	97,875 $4.46 Million

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.4B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

Stay updated on Point72 Europe (London) LLP with notifications on news.